Weitere Artikel dieser Ausgabe durch Wischen aufrufen
To assess the relationship between glycaemic control and quality of life (QoL) among a sample of Malaysians with type 2 diabetes mellitus.
This study is a cross-sectional hospital-based study involving 256 patients from three major ethnic groups in Malaysia. Data about QoL were collected with the 18-item Audit of Diabetes Dependent QoL questionnaire. Other data about putative predictors of QoL including personal characteristics and disease-related factors were also collected. Hierarchical multiple linear regression was used to determine factors associated with QoL and to control for confounding variables.
The mean age of participants was 56.79 years. Participants were mostly women, employed and married and had attained secondary education. More than a third of the patients had a disease duration of more than 10 years, and about two-thirds had HbA1c ≥ 6.5 %. Those with desired glycaemic control had poorer QoL than those with less than desired glycaemic control moderated by the use of insulin. Hierarchical multiple linear regression showed that desired glycaemic control (HbA1c), diabetes worry, use of insulin, more than 10 years’ duration of diabetes, neuropathy and retinopathy were associated with poor QoL, whereas being satisfied with waiting time for consultation was associated with better QoL.
The results of this study show that diabetes was associated with negative impact on quality of life. The use of insulin to achieve desired glycaemic control was particularly associated with negative impact on QoL.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Pandey, A., Tripathi, P., Pandey, R., Srivatava, R., & Goswami, S. (2011). Alternative therapies useful in the management of diabetes: A systematic review. Journal of Pharmacy & Bioallied Sciences, 3(4), 504. CrossRef
Population Distribution and Basic Demographic Characteristics 2010 (2011). Putra Jaya: Department of Statistics Malaysia.
Letchuman, G., Wan Nazaimoon, W., Wan Mohamad, W., Chandran, L., Tee, G., Jamaiyah, H., et al. (2010). Prevalence of diabetes in the Malaysian national health morbidity survey III 2006. Medical Journal of Malaysia, 65(3), 173–179.
Causes of death in Malaysia 2008. Department of Statistics Malaysia. http://www.statistics.gov.my. Accessed 20 October 2011.
Faudzi, A. Y., Nasir, A., Gurpreet, K., Vos, T., Chalapati, V. P., & Stephen, B. (2004). Malaysia burden of disease and injury study. Kuala Lumpur: Institute for Public Health, Ministry of Health.
Abougalambou, S. S. I., & Abougalambou, A. S. (2013). A study evaluating prevalence of hypertension and risk factors affecting on blood pressure control among type 2 diabetes patients attending teaching hospital in Malaysia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 7(2), 83–86. CrossRef
Institute for Public Health. (2011). National Health and Morbidity Survey 2011 (NHMS 2011). Vol. 1: Methodology and general findings.
Lau, C., Qureshi, A., & Scott, S. (2004). Association between glycaemic control and quality of life in diabetes mellitus. Journal of Postgraduate Medicine, 50(3), 189–194. PubMed
Weinberger, M., Kirkman, M. S., Samsa, G. P., Cowper, P. A., Shortliffe, E. A., Simel, D. L., et al. (1994). The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. Medical Care, 32(12), 1173–1181.
Kamarul, Imran, M., Ismail, A., Naing, L., & Wan Mohamad, W. (2010). Type 2 diabetes mellitus patients with poor glycaemic control have lower quality of life scores as measured by the Short Form-36. Singapore Medical Journal, 51(2), 157–162.
Fischer, J. S., McLaughlin, T., Loza, L., Beauchamp, R., Schwartz, S., & Kipnes, M. (2004). The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: An office-based naturalistic study. Current Medical Research and Opinion, 20(11), 1703–1710. CrossRefPubMed
Houlden, R., Ross, S., Harris, S., Yale, J.-F., Sauriol, L., & Gerstein, H. C. (2007). Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: The Canadian INSIGHT Study. Diabetes Research and Clinical Practice, 78(2), 254–258. CrossRefPubMed
DCCTR Group. (1996). Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabetes Care, 19(3), 195–203. CrossRef
Mafauzy, M., Hussein, Z., & Chan, S. (2011). The status of diabetes control in Malaysia: Results of DiabCare 2008. Medical Journal of Malaysia, 66(3), 175–181. PubMed
Mazlina, M., Shamsul, A., & Jeffery, F. (2011). Health-related quality of life in patients with diabetic foot problems in Malaysia. Medical Journal of Malaysia, 66(3), 234–238. PubMed
Clinical Practice Guidelines: Management of Type 2 Diabetes Mellitus. (2009). http://www.moh.gov.my. Accessed February 2010.
Sokal, R. R., & Rohlf, F. J. (1995). Biometry: The principals and practice of statistics in biological research. New York: WH Freeman.
Ashwell, S. G., Bradley, C., Stephens, J. W., Witthaus, E., & Home, P. D. (2008). Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes. Diabetes Care, 31(6), 1112–1117. CrossRefPubMed
Kamarul Imran, M., Ismail, A., Naing, L., & Wan Mohamad, W. (2004). Sf-36 and the Malay translated audit of dependent diabetes quality of life (ADDQOL) performances among type 2 diabetes patients. Community Health, 10(S), 55–58.
UK Prospective Diabetes Study Group. (1999). Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care, 22(7), 1125–1136. CrossRef
Rubin, R. R., & Peyrot, M. (1999). Quality of life and diabetes. Diabetes/Metabolism Reviews, 15, 205–218. CrossRef
Redekop, W. K., Koopmanschap, M. A., Stolk, R. P., Rutten, G. E. H. M., Wolffenbuttel, B. H. R., & Niessen, L. W. (2002). Health-related quality of life and treatment satisfaction in dutch patients with type 2 diabetes. Diabetes Care, 25(3), 458–463. doi: 10.2337/diacare.25.3.458. CrossRefPubMed
Wexler, D., Grant, R., Wittenberg, E., Bosch, J., Cagliero, E., Delahanty, L., et al. (2006). Correlates of health-related quality of life in type 2 diabetes. Diabtologia, 49(7), 1489–1497. CrossRef
Braun, A., Sämann, A., Kubiak, T., Zieschang, T., Kloos, C., Müller, U. A., et al. (2008). Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus. Patient Education and Counseling, 73(1), 50–59. CrossRefPubMed
Varghese, R. T., Salini, R., Abraham, P., Reeshma, K., & Vijayakumar, K. (2007). Determinants of the quality of life among diabetic subjects in Kerala, India. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 1(3), 173–179. CrossRef
Adriaanse, M. C., Dekker, J. M., Spijkerman, A. M., Twisk, J. W., Nijpels, G., van der Ploeg, H. M., et al. (2005). Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: The hoorn screening study. Quality of Life Research, 14(6), 1501–1509. CrossRefPubMed
Cohen, J., Cohen, P., West, S. G., & Aiken, L. S. (2013). Applied multiple regression/correlation analysis for the behavioral sciences. London: Routledge.
- Glycaemic control and quality of life among ethnically diverse Malaysian diabetic patients
Aqil Mohammad Daher
Syed Ahmad H. AlMashoor
- Springer International Publishing
Neuer Inhalt/© Stellmach, Neuer Inhalt/© Maturus, Pluta Logo/© Pluta